CANSINO BIOLOGICS IN

6185

End-of-day quote - 01/18
244.6HKD	+4.44%

Prev.	234.2000
Open	232.8000
High	244.6000
Low	228.0000
Volume	802 824

16h ago	Mexico aims to make up for Pfizer vaccine shortfall with others
16h ago	Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use
18h ago	Mexico aims to make up for Pfizer vaccine shortfall with others
01/11	Malaysia imposes 2-week lockdown as virus spread strains hospitals

	Short Term	Mid-Term	Long Term
Trend	Bullish	Neutral	Bullish
Resistance	249	271	271
Spread/Res.	-1,8%	-9,9%	-9,9%
Spread/Supp.	31%	71%	71%
Support	187	143	143

Sales 2020	94,1 M 14,5 M 14,5 M
Net income 2020	-6,87 M -1,06 M -1,06 M
Net cash 2020	2 901 M 448 M 448 M
P/E ratio 2020	-8 148x
Yield 2020	-

Capitalization	69 528 M 10 713 M 10 732 M
EV / Sales 2020	708x
EV / Sales 2021	18,0x
Nbr of Employees	429
Free-Float	37,1%

CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in...

>> Read more

Sector :

Biopharmaceuticals

Calendar :

2021-03-29 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	BUY
Number of Analysts	6
Average target price	171,22 CNY
Last Close Price	204,75 CNY
Spread / Highest target	6,17%
Spread / Average Target	-16,4%
Spread / Lowest Target	-77,5%